Fourth Nitrosamine Implementation Oversight Group (NIOG) meeting
Table of contents
Date:
30/11/2022
The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.
The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.
-
List item
Agenda - Fourth meeting of the Nitrosamine Implementation Oversight Group - Industry Associations (PDF/193.23 KB)
First published: 07/02/2023
EMA/735648/2022 -
List item
Presentation - Fourth meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry (PDF/712.63 KB)
First published: 07/02/2023 -
List item
Industry presentation - Fourth meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry (PDF/1.21 MB)
First published: 07/02/2023 -
List item
Industry presentation (2) - Fourth meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry (PDF/714.96 KB)
First published: 07/02/2023 -
List item
Highlights from the fourth meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry (PDF/191.64 KB)
First published: 07/02/2023